GW&K Investment Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $189K | Buy |
641
+33
| +5% | +$9.8K | ﹤0.01% | 397 |
|
|
2025
Q4 | $166K | Buy |
608
+1
| +0.2% | +$272 | ﹤0.01% | 410 |
|
|
2025
Q3 | $164K | Buy |
607
+53
| +10% | +$14.4K | ﹤0.01% | 405 |
|
|
2025
Q2 | $153K | Buy |
554
+47
| +9% | +$12.8K | ﹤0.01% | 397 |
|
|
2025
Q1 | $135K | Buy |
507
+13
| +3% | +$3.21K | ﹤0.01% | 393 |
|
|
2024
Q4 | $115K | Buy |
494
+13
| +3% | +$2.99K | ﹤0.01% | 395 |
|
|
2024
Q3 | $106K | Buy |
481
+11
| +2% | +$2.28K | ﹤0.01% | 390 |
|
|
2024
Q2 | $92K | Buy |
470
+25
| +6% | +$5.17K | ﹤0.01% | 394 |
|
|
2024
Q1 | $96K | Buy |
445
+203
| +84% | +$42.6K | ﹤0.01% | 379 |
|
|
2023
Q4 | $51K | Buy |
242
+5
| +2% | +$1.07K | ﹤0.01% | 403 |
|
|
2023
Q3 | $47K | Buy |
237
+92
| +63% | +$18.3K | ﹤0.01% | 397 |
|
|
2023
Q2 | $27K | Buy |
+145
| New | +$26.8K | ﹤0.01% | 437 |
|
|
2023
Q1 | – | Sell |
-152
| Closed | -$26K | – | 498 |
|
|
2022
Q4 | $26K | Buy |
152
+92
| +153% | +$16K | ﹤0.01% | 348 |
|
|
2022
Q3 | $11K | Sell |
60
-217
| -78% | -$42.9K | ﹤0.01% | 353 |
|
|
2022
Q2 | $57K | Sell |
277
-190
| -41% | -$40.3K | ﹤0.01% | 376 |
|
|
2022
Q1 | $111K | Sell |
467
-253
| -35% | -$59.4K | ﹤0.01% | 345 |
|
|
2021
Q4 | $164K | Sell |
720
-123,247
| -99% | -$27.1M | ﹤0.01% | 345 |
|
|
2021
Q3 | $24M | Sell |
123,967
-56,099
| -31% | -$11.4M | 0.21% | 180 |
|
|
2021
Q2 | $38.3M | Sell |
180,066
-31
| -0% | -$6.54K | 0.33% | 135 |
|
|
2021
Q1 | $36.8M | Sell |
180,097
-12,739
| -7% | -$2.51M | 0.34% | 133 |
|
|
2020
Q4 | $35.1M | Sell |
192,836
-1,423
| -0.7% | -$242K | 0.37% | 122 |
|
|
2020
Q3 | $32.5M | Sell |
194,259
-2,755
| -1% | -$464K | 0.43% | 93 |
|
|
2020
Q2 | $32M | Buy |
197,014
+12,532
| +7% | +$2.25M | 0.45% | 80 |
|
|
2020
Q1 | $31.9M | Buy |
184,482
+15,710
| +9% | +$3.13M | 0.56% | 56 |
|
|
2019
Q4 | $33.9M | Sell |
168,772
-414
| -0.2% | -$84.9K | 0.45% | 82 |
|
|
2019
Q3 | $35.8M | Buy |
169,186
+478
| +0.3% | +$99.9K | 0.5% | 67 |
|
|
2019
Q2 | $32.7M | Sell |
168,708
-3,224
| -2% | -$594K | 0.5% | 71 |
|
|
2019
Q1 | $28.3M | Sell |
171,932
-1,494
| -0.9% | -$264K | 0.46% | 84 |
|
|
2018
Q4 | $32.6M | Sell |
173,426
-5,114
| -3% | -$944K | 0.64% | 40 |
|
|
2018
Q3 | $30.4M | Sell |
178,540
-3,829
| -2% | -$645K | 0.49% | 87 |
|
|
2018
Q2 | $29.9M | Buy |
182,369
+33,851
| +23% | +$5.53M | 0.49% | 78 |
|
|
2018
Q1 | $24M | Buy |
+148,518
| New | +$23.6M | 0.41% | 104 |
|
Other funds holding CME
VCM
VPM
GW&K Investment Management's CME Position: Q1 2026 in Review
GW&K Investment Management increased its CME Group (CME) stake by 5.4% in Q1 2026, buying an estimated $9.8K and bringing the position to 641 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #397.
GW&K Investment Management first reported a position in CME in Q1 2018 and has held it in 32 quarters since. The position peaked at $38.3M in Q2 2021. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- GW&K Investment Management held 641 shares of CME Group worth $189K as of Q1 2026.
- GW&K Investment Management bought 33 CME Group shares in Q1 2026, an estimated $9.8K.
- CME Group made up ﹤0.01% of GW&K Investment Management's portfolio in Q1 2026, its #397 holding.
- GW&K Investment Management first reported a position in CME Group in Q1 2018 and has held it in 32 quarters since.
- GW&K Investment Management's CME Group position peaked at $38.3M in Q2 2021.
- 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.